The accurate, consistent, and scalable estimation of cerebellar atrophy would be highly beneficial for clinical trials in multiple system atrophy (MSA)1-3.
We use cookies to understand more about who's visiting our website, and, where we can, to provide you with a more tailored service. You can change your cookie settings at any time.